Researchmoz added Most up-to-date research on "Hemostats and Tissue Sealants In Global Market Expected To Grow At A CAGR Of 8.72% Between The Period 2016 - 2020" to its huge collection of research reports.
Blood clotting or coagulation, is an important process that eliminates excessive bleeding when a blood vessel is damaged. Platelets and proteins work together to stop the bleeding by forming a clot over the injury. Blood clottage is one of the mechanisms that reduce the loss of blood from damaged blood vessels.
Hemostats and tissue sealants are used post-surgery or traumatic injury to bind or hold external tissue (skin) as well as internal tissue (blood vessels). Some key types of hemostats and tissue sealants include fibrin sealants, collagen-based compounds, synthetic agents, and tissue adhesive glues such as hydrogels and glutaraldehyde glues. Fibrin sealants have a wide range of medical applications.
Technavios analysts forecast the global hemostats and tissue sealants market to grow at a CAGR of 8.72% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global hemostats and tissue sealants market for 2016-2020. To calculate the market size, Technavio uses revenue generated from the following products:
Topical hemostats (active hemostats, mechanical hemostats, and flowable hemostats)
Tissue sealants (fibrin and synthetic sealants)
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Technavio's report, Global Hemostats and Tissue Sealants Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
Advanced Medical Solutions Group
Baxter International
C. R. Bard
Cryolife
CSL Behring
Integra LifeSciences
Johnson & Johnson (Ethicon)
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=741777
Other prominent vendors
B. Braun
Cardinal Health
Cohera Medical
Haemacure
HyperBranch Medical Technology
NeoMend
Smith & Nephew
Teijin Pharma
Tissuemed
Vascular Solutions
Vivostat
Z-Medica
Market driver
Focus on patient safety and quicker recovery
For a full, detailed list, view our report
Market challenge
Paucity of ready-to-use products
For a full, detailed list, view our report
Market trend
Approval of fibrin sealants as broad level hemostats
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=741777
Blood clotting or coagulation, is an important process that eliminates excessive bleeding when a blood vessel is damaged. Platelets and proteins work together to stop the bleeding by forming a clot over the injury. Blood clottage is one of the mechanisms that reduce the loss of blood from damaged blood vessels.
Hemostats and tissue sealants are used post-surgery or traumatic injury to bind or hold external tissue (skin) as well as internal tissue (blood vessels). Some key types of hemostats and tissue sealants include fibrin sealants, collagen-based compounds, synthetic agents, and tissue adhesive glues such as hydrogels and glutaraldehyde glues. Fibrin sealants have a wide range of medical applications.
Technavios analysts forecast the global hemostats and tissue sealants market to grow at a CAGR of 8.72% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global hemostats and tissue sealants market for 2016-2020. To calculate the market size, Technavio uses revenue generated from the following products:
Topical hemostats (active hemostats, mechanical hemostats, and flowable hemostats)
Tissue sealants (fibrin and synthetic sealants)
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Technavio's report, Global Hemostats and Tissue Sealants Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
Advanced Medical Solutions Group
Baxter International
C. R. Bard
Cryolife
CSL Behring
Integra LifeSciences
Johnson & Johnson (Ethicon)
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=741777
Other prominent vendors
B. Braun
Cardinal Health
Cohera Medical
Haemacure
HyperBranch Medical Technology
NeoMend
Smith & Nephew
Teijin Pharma
Tissuemed
Vascular Solutions
Vivostat
Z-Medica
Market driver
Focus on patient safety and quicker recovery
For a full, detailed list, view our report
Market challenge
Paucity of ready-to-use products
For a full, detailed list, view our report
Market trend
Approval of fibrin sealants as broad level hemostats
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=741777
No comments:
Post a Comment